Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 6Peritoneal Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Gastric Adenocarcinoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Appendiceal Neoplasms 2Uterine Neoplasms 1Stomach Diseases 1Pseudomyxoma Peritonei 1Ovarian Epithelial Cancer Recurrent 1Locally Advanced Gastric Cancer 1Krukenberg Tumor 1HIPEC 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Cancer Peritoneal Metastases 1Digestive System Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Mitomycin 2tislelizumab 1molgramostim 1cryoprecipitate coagulum 1Tacrolimus 1Standard of Care 1Specimen Handling 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1CTLA-4 Antigen 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Hyperthermic Intraperitoneal Chemotherapy × 1 year × Clear all
NCT06513065 2026-02-19

HIPEC-PMP

University of Southampton

Phase 3 Recruiting
176 enrolled

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡